H-SER-LEU-ILE-GLY-LYS-VAL-NH2
|
|
|
- CAS-Nr.
- 190383-13-2
- Englisch Name:
- H-SER-LEU-ILE-GLY-LYS-VAL-NH2
- Synonyma:
- SLIGKV-NH2;Par-2 Ago;SLIGKVAMIDE;PAR-2 amide (1-6);PAR-2 AGONIST AMIDE;PAR-2 Agonist, amid;SLIGKV-NH2 TFA salt;PAR2 activating peptide;PAR-2 (1-6) AMIDE (HUMAN);SER-LEU-ILE-GLY-LYS-VAL-NH2
- CBNumber:
- CB7715297
- Summenformel:
- C28H54N8O7
- Molgewicht:
- 614.78
- MOL-Datei:
- 190383-13-2.mol
|
H-SER-LEU-ILE-GLY-LYS-VAL-NH2 Eigenschaften
- Siedepunkt:
- 1030.3±65.0 °C(Predicted)
- Dichte
- 1.161±0.06 g/cm3(Predicted)
- storage temp.
- -20°C
- Löslichkeit
- ≥13.48 mg/mL in EtOH with gentle warming and ultrasonic; ≥62.9 mg/mL in DMSO; ≥66.2 mg/mL in H2O
- Aggregatzustand
- solid
- pka
- 12.04±0.10(Predicted)
- Wasserlöslichkeit
- Soluble to 1 mg/ml in water
- Sequenz
- H-Ser-Leu-Ile-Gly-Lys-Val-NH2
Sicherheit
H-SER-LEU-ILE-GLY-LYS-VAL-NH2 Chemische Eigenschaften,Einsatz,Produktion Methoden
S-Sätze Betriebsanweisung:
S22:Staub nicht einatmen.
S24/25:Berührung mit den Augen und der Haut vermeiden.
Verwenden
SLIGKV-NH2 is a PAR2 agonist.
Biochem/physiol Actions
Proteinase-activated receptor (PAR-2) is a member of proteolytically cleaved receptors. It is activated by a synthetic peptide (SLIGKV), that is exposed after trypsin cleavage of the amino terminus. PAR-2 stimulates an increase in cytosolic Ca2+ ion concentration.
H-SER-LEU-ILE-GLY-LYS-VAL-NH2 Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
H-SER-LEU-ILE-GLY-LYS-VAL-NH2 Anbieter Lieferant Produzent Hersteller Vertrieb Händler.
Global( 94)Lieferanten
- PROTEASE-ACTIVATED RECEPTOR-2 AGONIST, AMIDE
- PROTEINASE ACTIVATED RECEPTOR 2 (1-6) AMIDE (HUMAN)
- PROTEINASE ACTIVATED RECEPTOR 2 AGONIST PEPTIDE SLIGKV AMIDE, HUMAN
- SER-LEU-ILE-GLY-LYS-VAL-AMIDE
- SER-LEU-ILE-GLY-LYS-VAL-NH2
- SLIGKVAMIDE
- SLIGKV-NH2
- PAR-2 AGONIST PEPTIDE (SLIGKV) AMIDE, HUMAN
- PAR-2 (1-6) AMIDE (HUMAN)
- PAR-2 AGONIST AMIDE
- THROMBIN RECEPTOR-LIKE 1 (1-6) AMIDE (HUMAN)
- COAGULATION FACTOR II RECEPTOR-LIKE 1 (1-6) AMIDE (HUMAN)
- H-SER-LEU-ILE-GLY-LYS-VAL-NH2
- Par-2 Ago
- Protease - Activated Receptor - 2, PAR - 2 Agonist, amide
- ThroMbin Receptor-Like 1 (1-6) aMide (huMan), SLIGKVaMide, Proteinase Activated Receptor 2 (1-6) aMide (huMan), Coagulation Factor II Receptor-Like 1 (1-6) aMide (huMan)
- PAR2 activating peptide
- Protease-Activated Receptor-2, amide (SLIGKV-NH2)
- L-Valinamide, L-seryl-L-leucyl-L-isoleucylglycyl-L-lysyl-
- Ser-Leu-Ile-Gly-Lys-Val-amide >=95% (HPLC), solid
- Protease-activated receptor 2 (PAR2) agonist(SLIGKV-NH2)
- H-SER-LEU-ILE-GLY-LYS-VAL-NH2 USP/EP/BP
- ProteaseActivated Receptor2, amide,Protease Activated Receptor (PAR),Inhibitor,Thrombin receptors,inhibit,Protease Activated Receptor 2, amide
- L-Seryl-L-leucyl-L-isoleucylglycyl-L-lysyl-L-valinamide
- PAR-2 Agonist, amid
- PAR-2 amide (1-6)
- SLIGKV-NH2 TFA salt
- 190383-13-2
- C28H54N8O7
- Immune Cell Signaling and Blood
- Immune System Regulation
- Immunomodulators and Antibiotics
- Cell Biology
- Cell Signaling and Neuroscience
- BioChemical
- peptide
- Immune Cell Signaling and Blood
- Immune System Regulation
- Immunomodulators and Antibiotics
